Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03345160 · ClinicalTrials.gov registry record · Phase 2
Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT03345160: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT03345160 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03345160, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
This application is being submitted as a follow-up to Protocol "Oral Immunotherapy for Induction of Tolerance in Peanut Allergic Children-The IMPACT Study." The IMPACT study was a double-blind, placebo-controlled study of peanut oral immunotherapy in children 12-48 months of age. As part this protocol, all participants who received placebo treatment were promised the opportunity to receive open label treatment at the conclusion of the double-blind phase and initial follow-up. At the time of submitting that protocol, the investigator did not specify any detailed protocol for the open label crossover treatment, as this is an evolving field, but the investigator is now ready to offer this open label treatment as promised.
Interventions
- DRUG Peanut Flour
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-04-27 |
| Est. Completion | 2020-10-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03345160
The ClinicalTrials.gov registry entry for NCT03345160 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peanut Flour is the first listed.
NCT03345160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03345160 about?
NCT03345160 is a clinical study titled "Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study". This application is being submitted as a follow-up to Protocol "Oral Immunotherapy for Induction of Tolerance in Peanut Allergic Children-The IMPACT Study." The IMPACT study was a double-blind, placebo-controlled study of peanut oral immunotherapy in children 12-48 months of age. As part this protoc...
What is the current status of trial NCT03345160?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2018-04-27. Estimated completion is 2020-10-07.
What interventions are being tested in trial NCT03345160?
The interventions under investigation include: Peanut Flour (DRUG).
Who is sponsoring clinical trial NCT03345160?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.